UPM-Kymmene Oyj (UPM.he) - Financial summary and valuation
UPM-Kymmene Oyj

Company Overview

UPM is a global leader in forest-based bioindustries, offering a wide range of innovative solutions for various industries. With its rich history dating back to 1929, UPM has evolved into a multinational corporation with operations in over 30 countries. The company's primary mission is to create sustainable growth by developing and delivering high-quality products and services that meet the needs of its customers.

UPM's core values are built around innovation, sustainability, and customer satisfaction. The company strives to be a responsible business partner, committed to creating long-term value for its stakeholders. UPM's vision is to be the world's leading forest-based bioindustrial company, with a focus on sustainable growth and innovation.

Key Products/Services

UPM offers a diverse range of products and services that cater to various industries, including paper, packaging, tissue, biofuels, and wood products. Some of the key benefits of UPM's products include:

UPM's innovative solutions are designed to meet the evolving needs of its customers, while minimizing its environmental footprint. The company's commitment to sustainability is reflected in its use of renewable resources, reduction of waste, and implementation of energy-efficient technologies.

Innovation and Sustainability

UPM has a strong focus on innovation and sustainability, with a range of initiatives aimed at reducing its environmental impact. Some of the company's notable initiatives include:

UPM's commitment to innovation and sustainability has earned the company numerous awards and recognition, including being named one of the world's most sustainable companies by Corporate Knights.

Investment Opportunity

UPM presents a compelling investment opportunity for those looking to capitalize on the growing demand for sustainable products and services. With its strong brand reputation, diverse product portfolio, and commitment to innovation and sustainability, UPM is well-positioned to continue delivering long-term value to its stakeholders.

The company's financial performance has been strong in recent years, with revenue growth driven by increasing demand for its bio-based products and services. UPM's dividend policy provides a stable source of income for investors, while the company's expansion into new markets and product areas presents opportunities for further growth and profitability.



Valuation

2022 2023 2024 2025 2026 (e) 2027 (e) 2028 (e)
Number of Shares (million) 533.7 533.7 533.7 527.7 527.7 527.7 527.7
Target Valuation (MEur) 9659.8 10822.0 9362.0 9785.1 7890.6 5853.8 5853.8
Targer Price 18.1 20.28 17.54 18.54 14.95 11.09 11.09
Potential, % -48.2 -40.5 -34.5 -25.2 -34.4 -51.3 -51.3
Recommendation Sell Sell Sell Sell Sell Sell Sell
MCAP (MEur) 18643.4 18179.0 14293.4 13082.6 12027.1 12027.1 12027.1
Price 34.93 34.06 26.78 24.79 22.79 22.79 22.79
EV 21017.0 20611.0 17162.0 16087.0 15252.0 14199.0 13317.0
P/S 1.59 1.74 1.38 1.35 1.21 1.2 1.25
EV/S 1.79 1.97 1.66 1.67 1.54 1.42 1.38
EV/EBIT 10.16 33.9 14.33 21.45 15.95 16.03 16.97
P/E 11.42 46.26 15.23 26.7 15.87 16.97 19.15
P/B 1.49 1.63 1.28 1.31 1.16 1.09 1.03
P/OCF 36.7 8.01 10.58 9.3 23.16 8.21 9.3
EV/OCF 41.37 9.08 12.7 11.44 29.37 9.69 10.29
P/FCF -17.31 15.21 18.71 13.38 60.36 11.42 13.64
EV/FCF -19.51 17.25 22.46 16.45 76.54 13.49 15.11

Income Statement

2022 2023 2024 2025 2026 (e) 2027 (e) 2028 (e)
Revenue 11720.0 10460.0 10339.0 9656.0 9930.9 9986.2 9628.1
Rev. Growth, % 19.4 -10.8 -1.2 -6.6 2.8 0.6 -3.6
Ebit 2069.0 608.0 1198.0 750.0 956.3 885.9 784.9
Ebit Growth, % 32.5 -70.6 97.0 -37.4 27.5 -7.4 -11.4
Ebit, % 17.7 5.8 11.6 7.8 9.6 8.9 8.2
Profit 1632.0 393.0 938.2 490.0 757.6 708.7 627.9
EPS 3.06 0.74 1.76 0.93 1.44 1.34 1.19
Profit Growth, % 24.9 -75.9 138.7 -47.8 54.6 -6.5 -11.4
Profit, % 13.9 3.8 9.1 5.1 7.6 7.1 6.5

Balance Sheet

2022 2023 2024 2025 2026 (e) 2027 (e) 2028 (e)
Inventory 2289.0 1948.0 2104.0 1886.0 1897.8 1566.2 1628.9
Acc. Receivable 2696.0 1782.0 1929.0 1481.0 2235.7 2343.9 2250.5
Cash 2067.0 632.0 892.0 715.0 546.3 1599.1 2480.7
Equity 12502.0 11161.0 11139.0 10001.0 10338.7 11047.4 11675.3
ROE, % 13.1 3.5 8.4 4.9 7.3 6.4 5.4
ROCE, % 12.2 4.3 8.0 5.5 6.8 6.0 5.1
Net Debt 2374.0 2432.0 2869.0 3004.0 3224.7 2171.9 1290.3
Gearing, % 19.0 21.8 25.8 30.0 31.2 19.7 11.1
Equity ratio, % 56.3 60.4 58.3 57.0 57.3 68.8 72.4
Acc. Payable 2720.0 1883.0 1938.0 1839.0 1826.5 2705.5 2485.4
Total Assets 22207.0 18473.0 19096.0 17532.0 18047.4 16067.7 16124.1
ROA, % 7.3 2.1 4.9 2.8 4.2 4.4 3.9

Cash Flow

2022 2023 2024 2025 2026 (e) 2027 (e) 2028 (e)
Operating Cash Flow 508.0 2270.0 1351.0 1406.0 519.3 1464.8 1293.6
Investment Cash Flow -1585.0 -1075.0 -587.0 -428.0 -320.0 -412.0 -412.0
Free Cash Flow -1077.0 1195.0 764.0 978.0 199.3 1052.8 881.6
OCF/CAPEX 0.32 2.11 2.3 3.29 1.62 3.56 3.14
Financial Cash Flow 1688.0 -2572.0 -544.0 -1134.0 -363.0 0.0 0.0




Tulikivi Oyj United Bankers Oyj









Disclaimer

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.

Before deciding to trade in financial instrument you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.

The data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Contact: quant@quantfactory.eu